Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 47 Neoplasm Metastasis 9 Neoplasms 8 Prostatic Neoplasms 7 Brain Neoplasms 7 Endometrial Neoplasms 6 Glioblastoma 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Ovarian Neoplasms 4 Head and Neck Neoplasms 4 Meningioma 3 Carcinoma, Renal Cell 3 Sarcoma 2 Recurrence 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Oligodendroglioma 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Liposarcoma 2 Hematologic Neoplasms 2 Glioma 2 Breast Neoplasms, Male 2 Breast Diseases 2 Breast Cancer Female 2 Venous Thromboembolism 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1

Interventions

ribociclib 1 palbociclib 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × DILI × abemaciclib × Clear all

NCT06367335 2024-04-16

ETIC

University of Milano Bicocca

DILI

Data powered by HemOnc (CC BY 4.0) Colophon ⚡